Suppr超能文献

再次手术切除复发性岛叶胶质瘤的围手术期结果。

Perioperative outcomes following reoperation for recurrent insular gliomas.

机构信息

1Department of Neurological Surgery, University of California, San Francisco, California; and.

2Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon.

出版信息

J Neurosurg. 2018 Sep 21;131(2):467-473. doi: 10.3171/2018.4.JNS18375. Print 2019 Aug 1.

Abstract

OBJECTIVE

Greater extent of resection (EOR) improves overall survival and progression-free survival for patients with low- and high-grade glioma. While resection for newly diagnosed insular gliomas can be performed with minimal morbidity, perioperative morbidity is not clearly defined for patients undergoing a repeat resection for recurrent insular gliomas. In this study the authors report on tumor characteristics, tumor EOR, and functional outcomes in patients undergoing reoperation for recurrent insular glioma.

METHODS

Adult patients with insular gliomas (WHO grades II-IV) who underwent index resection followed by reoperation were identified through the University of California San Francisco Brain Tumor Center. Treatment history and functional outcomes were collected retrospectively from the electronic medical record. Pre- and postoperative tumor volumes were quantified using software with region-of-interest analysis based on FLAIR and T1-weighted postgadolinium sequences from pre- and postoperative MRI.

RESULTS

Forty-four patients (63.6% male, 36.4% female) undergoing 49 reoperations for recurrent insular tumors were identified with a median follow-up of 741 days. Left- and right-sided tumors comprised 52.3% and 47.7% of the cohort, respectively. WHO grade II, III, and IV gliomas comprised 46.9%, 28.6%, and 24.5% of the cohort, respectively. Ninety-five percent (95.9%) of cases involved language and/or motor mapping. Median EOR of the insular component of grade II, III, and IV tumors were 82.1%, 75.0%, and 94.6%, respectively. EOR during reoperation was not impacted by Berger-Sanai insular zone or tumor side. At the time of reoperation, 44.9% of tumors demonstrated malignant transformation to a higher WHO grade. Ninety-day postoperative assessment confirmed that 91.5% of patients had no new postoperative deficit attributable to surgery. Of those with new deficits, 3 (6.4%) had a visual field cut and 1 (2.1%) had hemiparesis (strength grade 1-2/5). The presence of a new postoperative deficit did not vary with EOR.

CONCLUSIONS

Recurrent insular gliomas, regardless of insular zone and pathology, may be reoperated on with an overall acceptable degree of resection and safety despite their anatomical and functional complexities. The use of intraoperative mapping utilizing asleep or awake methods may reduce morbidity to acceptable rates despite prior surgery.

摘要

目的

更大程度的切除(EOR)可改善低级别和高级别脑胶质瘤患者的总生存率和无进展生存率。虽然对于新诊断的岛叶胶质瘤可以进行最小的发病率的切除,但是对于复发性岛叶胶质瘤患者进行重复切除的围手术期发病率尚不清楚。在这项研究中,作者报告了在复发性岛叶胶质瘤患者中进行再手术时的肿瘤特征、肿瘤 EOR 和功能结果。

方法

通过加利福尼亚大学旧金山脑肿瘤中心,确定了接受首次切除后继发再手术的岛叶胶质瘤(WHO 分级 II-IV)的成年患者。通过电子病历回顾性收集治疗史和功能结果。使用基于 FLAIR 和 T1 加权钆后序列的感兴趣区分析软件,定量计算术前和术后的肿瘤体积。

结果

共确定了 44 名(63.6%为男性,36.4%为女性)接受 49 次复发性岛叶肿瘤再手术的患者,中位随访时间为 741 天。左、右侧肿瘤分别占队列的 52.3%和 47.7%。WHO 分级 II、III 和 IV 级胶质瘤分别占队列的 46.9%、28.6%和 24.5%。95%(95.9%)的病例涉及语言和/或运动定位。岛叶成分的 II 级、III 级和 IV 级肿瘤的中位 EOR 分别为 82.1%、75.0%和 94.6%。再手术期间的 EOR 不受 Berger-Sanai 岛叶区或肿瘤侧的影响。在再手术时,44.9%的肿瘤发生恶性转化为更高的 WHO 分级。90 天术后评估证实,91.5%的患者无新的手术相关术后缺陷。在有新缺陷的患者中,3 例(6.4%)出现视野缺损,1 例(2.1%)出现偏瘫(肌力 1-2/5)。新的术后缺陷的出现与 EOR 无关。

结论

尽管具有解剖和功能上的复杂性,但复发性岛叶胶质瘤,无论岛叶区和病理学如何,都可以进行再次手术,切除程度总体上可接受且安全。尽管先前进行过手术,但使用术中映射(包括在睡眠或清醒状态下进行)可能会将发病率降低到可接受的水平。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验